Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
AI Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
AI Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Mirum Pharmaceuticals
Pharma
Mirum keeps momentum with ph. 3 win for Livmarli
Mirum boasts another win for its anti-itch pipeline with Livmarli phase 3 results.
Donavyn Coffey
Oct 12, 2026 11:18am
Mirum scores FDA approval for ultra-rare disorder
Sep 25, 2026 4:10pm
Ipsen's liver disease drug Bylvay fails biliary atresia trial
Jul 24, 2026 11:00am
Mirum's Ctexli scores FDA approval in rare metabolic disorder
Feb 21, 2025 3:30pm
Mirum gets 2nd indication for blockbuster hopeful Livmarli
Mar 13, 2024 6:20pm
Travere cuts 20% of workforce, aims to win full nod for Filspari
Dec 5, 2023 11:26am
